Saturna Capital Corp Abbott Laboratories Transaction History

Saturna Capital Corp

$7.5 Billion
Q3 2024

A detailed history of Saturna Capital Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Saturna Capital Corp holds 394,071 shares of ABT stock, worth $45 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

394,071

Previous 407,104 3.2%

Holding current value

$45 Million

Previous $42.3 Million 6.21%

% of portfolio

0.6%

Previous 0.57%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$100.07 - $118.13 $1.3 Million - $1.54 Million	-13,033 Reduced 3.2%	394,071 $44.9 Million
Q2 2024 Jul 31, 2024	SELL	$100.73 - $112.44 $1.71 Million - $1.91 Million	-16,994 Reduced 4.01%	407,104 $42.3 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $308,846 - $341,107	-2,820 Reduced 0.66%	424,098 $48.2 Million
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $520,666 - $637,339	-5,773 Reduced 1.33%	426,918 $47 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $370,178 - $444,152	-3,875 Reduced 0.89%	432,691 $41.9 Million
Q2 2023 Aug 04, 2023	BUY	$100.78 - $112.29 $287,726 - $320,587	2,855 Added 0.66%	436,566 $47.6 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $86,495 - $101,810	893 Added 0.21%	433,711 $43.9 Million
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $508,761 - $596,855	-5,352 Reduced 1.22%	432,818 $47.5 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $29,028 - $33,609	-300 Reduced 0.07%	438,170 $42.4 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $72,571 - $87,716	-711 Reduced 0.16%	438,470 $47.6 Million
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $222,224 - $270,988	1,949 Added 0.45%	439,181 $52 Million
Q4 2021 Feb 09, 2022	BUY	$115.53 - $141.46 $21,835 - $26,735	189 Added 0.04%	437,232 $59.6 Million
Q3 2021 Nov 08, 2021	BUY	$116.66 - $129.06 $273,801 - $302,903	2,347 Added 0.54%	437,043 $51.6 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $204,174 - $240,342	1,930 Added 0.45%	434,696 $50.4 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $346,437 - $408,156	3,183 Added 0.74%	432,766 $51.9 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $1,050 - $1,144	-10 Reduced -0.0%	429,583 $47 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $42,887 - $52,083	468 Added 0.11%	429,593 $46.8 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $6,282 - $9,186	100 Added 0.02%	429,125 $33.9 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $24,552 - $26,622	-300 Reduced 0.07%	429,025 $35.9 Million
Q2 2019 Jul 31, 2019	BUY	$72.88 - $85.0 $18,001 - $20,995	247 Added 0.06%	429,325 $36.1 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $303,420 - $366,834	-4,582 Reduced 1.06%	429,078 $34.3 Million
Q4 2018 Feb 08, 2019	SELL	$65.56 - $74.27 $19,668 - $22,281	-300 Reduced 0.07%	433,660 $31.4 Million
Q2 2018 Aug 02, 2018	SELL	$57.57 - $63.54 $43,925 - $48,481	-763 Reduced 0.18%	433,960 $26.5 Million
Q1 2018 May 10, 2018	SELL	$56.27 - $63.62 $119,798 - $135,446	-2,129 Reduced 0.49%	434,723 $26 Million
Q4 2017 Feb 06, 2018	BUY	$53.68 - $57.47 $45,091 - $48,274	840 Added 0.19%	436,852 $24.9 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $9,804 - $10,942	-204 Reduced 0.05%	436,012 $23.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	436,216	436,216 $21.2 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.

Account

Saturna Capital Corp Abbott Laboratories Transaction History